|
|
||||||||
Departments of 1 Nutritional Sciences and 2 Paediatrics, University of Toronto, Toronto M5S 3E2; 3 The Research Institute, The Hospital for Sick Children, Toronto, Ontario M5G 1X8; and 4 Department of Agricultural, Food and Nutritional Services, University of Alberta, Edmonton, Alberta, Canada T6G 2P5
Dietary restriction of
phenylalanine is the main treatment for phenylketonuria (PKU), and
current estimates of requirements are based on plasma phenylalanine
concentration and growth. The present study aimed to determine more
precisely the phenylalanine requirements in patients with the disease
by use of indicator amino acid oxidation, with
L-[1-13C]lysine as the indicator. Breath
13CO2 production
(F13CO2) was used as the end point.
Finger-prick blood samples were also collected for measurement of
phenylalanine to relate phenylalanine intake to blood phenylalanine
levels. The mean phenylalanine requirement, estimated using a two-phase
linear regression crossover analysis, was 14 mg · kg
1 · day
1,
and the safe population intake (upper 95% confidence interval of the
mean) was found to be 19.5 mg · kg
1 · day
1.
A balance between phenylalanine intake and the difference between fed
and fasted blood phenylalanine concentration was observed at an intake
of 20 mg · kg
1 · day
1.
The similarity between these two values (19.5 and 20 mg · kg
1 · day
1)
suggests that the maximal phenylalanine intake for children with PKU
should be no higher than 20 mg · kg
1 · day
1.
phenylketonuria; amino acid requirements; lysine
This article has been cited by other articles:
![]() |
R. Elango, M. A. Humayun, R. O. Ball, and P. B. Pencharz Indicator Amino Acid Oxidation Is Not Affected by Period of Adaptation to a Wide Range of Lysine Intake in Healthy Young Men J. Nutr., June 1, 2009; 139(6): 1082 - 1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Elango, R. O. Ball, and P. B. Pencharz Indicator Amino Acid Oxidation: Concept and Application J. Nutr., February 1, 2008; 138(2): 243 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Pencharz, J. W-C. Hsu, and R. O. Ball Aromatic Amino Acid Requirements in Healthy Human Subjects J. Nutr., June 1, 2007; 137(6): 1576S - 1578S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W-C. Hsu, W. Kriengsinyos, L. J. Wykes, M. Rafii, L. A. Goonewardene, R. O. Ball, and P. B. Pencharz Leucine Is Not a Good Choice as an Indicator Amino Acid for Determining Amino Acid Requirements in Men J. Nutr., April 1, 2006; 136(4): 958 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W-C Hsu, L. A Goonewardene, M. Rafii, R. O Ball, and P. B Pencharz Aromatic amino acid requirements in healthy men measured by indicator amino acid oxidation Am. J. Clinical Nutrition, January 1, 2006; 83(1): 82 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Mager, L. J. Wykes, E. A. Roberts, R. O. Ball, and P. B. Pencharz Branched-Chain Amino Acid Needs in Children with Mild-to-Moderate Chronic Cholestatic Liver Disease J. Nutr., January 1, 2006; 136(1): 133 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Riazi, M. Rafii, J. T. R. Clarke, L. J. Wykes, R. O. Ball, and P. B. Pencharz Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E142 - E149. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Pencharz and R. O. Ball Amino Acid Needs for Early Growth and Development J. Nutr., June 1, 2004; 134(6): 1566S - 1568S. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |